Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Inks BAC-Array CGH Lab Service Deals With Two Genetics Labs

This updates includes confirmation that Southwest Genetics is one of CMDX's two new partners.

NEW YORK (GenomeWeb News) – CombiMatrix today said that its molecular diagnostics subsidiary has penned two partnerships for its newly launched BAC-array comparative genomic hybridization “Technical Only Program.”

Under the deals, the partners will take orders and receive samples, but all of the technical lab testing will be conducted at CMDX’s facilities. The data will be delivered to the partner electronically, who will interpret the information.
CombiMatrix did not name the partners, but in a statement released this morning the company quoted spokespeople from Molecular Genetics, a diagnostic and clinical core laboratory at the
University of
Michigan, and Southwest Genetics, a private genetics reference laboratory in
San Antonio, Texas.

Greg Mengden, director of Southwest Genetics, today confirmed that his company "selected [CMDX] as the provider of that service.”

A call to Molecular Genetics and CMDX were not returned.

Financial terms of the agreements were not released.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.